Quality of life and health status after prophylactic salpingo-oophorectomy in women who carry a BRCA mutation: A review

Maturitas

Volumn 70, Issue 3, 2011, Pages 261-265

  Finch, Amy ^a   Narod, Steven A ^a  

^a WOMEN S COLLEGE HOSPITAL   (Canada)

Author keywords

BRCA1; BRCA2; Prophylactic salpingo oophrectomy; Surgical menopause

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADRENERGIC SYSTEM; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CANCER SURVIVAL; COGNITION; DISTRESS SYNDROME; DYSPAREUNIA; GENE MUTATION; HEALTH STATUS; HETEROZYGOTE; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; MENOPAUSE; OSTEOLYSIS; OVARY CANCER; OVERALL SURVIVAL; PATIENT SATISFACTION; PROPHYLAXIS; QUALITY OF LIFE; REVIEW; SALPINGOOOPHORECTOMY; SEXUAL BEHAVIOR; SEXUAL FUNCTION; SYMPTOM; UTERINE TUBE TUMOR; VAGINAL DRYNESS;

ESTROGEN REPLACEMENT THERAPY; FALLOPIAN TUBE NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HEALTH STATUS; HOT FLASHES; HUMANS; MENOPAUSE; MUTATION; NEOPLASMS; OVARIAN NEOPLASMS; OVARIECTOMY; PATIENT SATISFACTION; POSTOPERATIVE COMPLICATIONS; QUALITY OF LIFE; SALPINGECTOMY; SEXUALITY;

EID: 80054105101     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2011.08.001     Document Type: Review

References (51)

1. D. Ford, D.F. Easton, and M. Stratton Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium Am J Hum Genet 62 3 1998 676 689 (Pubitemid 28164626)
2. J.P. Struewing, P. Hartge, and S. Wacholder The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews N Engl J Med 336 20 1997 1401 1408 (Pubitemid 27208598)
3. H.A. Risch, J.R. McLaughlin, and D.E. Cole Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer Am J Hum Genet 68 3 2001 700 710 (Pubitemid 32203724)
4. A. Antoniou, P.D. Pharoah, and S. Narod Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies Am J Hum Genet 72 5 2003 1117 1130 (Pubitemid 36530000)
5. M.C. King, J.H. Marks, and J.B. Mandell Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2 Science 302 5645 2003 643 646 (Pubitemid 37310920)
6. ACOG Practice Bulletin No. 103: Hereditary breast and ovarian cancer syndrome Obstet Gynecol 113 4 2009 957 966
7. NIH Consensus Conference Ovarian cancer. Screening, treatment, and follow-up. NIH Consensus Development Panel on Ovarian Cancer JAMA 273 6 1995 491 497
8. T.R. Rebbeck Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers Eur J Cancer 38 Suppl. 6 2002 S15 S17
9. N.D. Kauff, J.M. Satagopan, and M.E. Robson Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation N Engl J Med 346 21 2002 1609 1615 (Pubitemid 34755668)
10. A. Finch, M. Beiner, and J. Lubinski Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation JAMA 296 2 2006 185 192
11. T.R. Rebbeck, A.M. Levin, and A. Eisen Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers J Natl Cancer Inst 91 17 1999 1475 1479 (Pubitemid 29424552)
12. A. Eisen, J. Lubinski, and J. Klijn Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study J Clin Oncol 23 30 2005 7491 7496 (Pubitemid 46291812)
13. K.A. Metcalfe, P. Ghadirian, and B. Rosen Variation in rates of uptake of preventive options by Canadian women carrying the BRCA1 or BRCA2 genetic mutation Open Med 1 2 2007 e92 e98
14. K.A. Metcalfe, D. Birenbaum-Carmeli, and J. Lubinski International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers Int J Cancer 122 9 2008 2017 2022 (Pubitemid 351441190)
15. J.B. Madalinska, J. Hollenstein, and E. Bleiker Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer J Clin Oncol 23 28 2005 6890 6898
16. W.A. Rocca, B.R. Grossardt, M. de Andrade, G.D. Malkasian, and L.J. Melton 3rd Survival patterns after oophorectomy in premenopausal women: a population-based cohort study Lancet Oncol 7 10 2006 821 828 (Pubitemid 44464065)
17. W.A. Rocca, J.H. Bower, and D.M. Maraganore Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause Neurology 69 11 2007 1074 1083 (Pubitemid 47517552)
18. H.L. Judd Hormonal dynamics associated with the menopause Clin Obstet Gynecol 19 4 1976 775 788 (Pubitemid 8007370)
19. A.V. Sluijmer, M.J. Heineman, F.H. De Jong, and J.L. Evers Endocrine activity of the postmenopausal ovary: the effects of pituitary down-regulation and oophorectomy J Clin Endocrinol Metab 80 7 1995 2163 2167
20. C.L. Hughes Jr., L.L. Wall, and W.T. Creasman Reproductive hormone levels in gynecologic oncology patients undergoing surgical castration after spontaneous menopause Gynecol Oncol 40 1 1991 42 45
21. A. Eisen, J. Lubinski, and J. Gronwald Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers J Natl Cancer Inst 100 19 2008 1361 1367
22. T.R. Rebbeck, T. Friebel, and T. Wagner Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study group J Clin Oncol 23 31 2005 7804 7810 (Pubitemid 46657377)
23. L. Elit, M.J. Esplen, K. Butler, and S. Narod Quality of life and psychosexual adjustment after prophylactic oophorectomy for a family history of ovarian cancer Fam Cancer 1 3-4 2001 149 156
24. A. Fry, C. Busby-Earle, R. Rush, and A. Cull Prophylactic oophorectomy versus screening: psychosocial outcomes in women at increased risk of ovarian cancer Psychooncology 10 3 2001 231 241 (Pubitemid 32466048)
25. K. Tiller, B. Meiser, and P. Butow Psychological impact of prophylactic oophorectomy in women at increased risk of developing ovarian cancer: a prospective study Gynecol Oncol 86 2 2002 212 219 (Pubitemid 34953506)
26. M. Robson, M. Hensley, and R. Barakat Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy Gynecol Oncol 89 2 2003 281 287 (Pubitemid 36457877)
27. J.B. Madalinska, M. van Beurden, and E.M. Bleiker The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy J Clin Oncol 24 22 2006 3576 3582 (Pubitemid 46630529)
28. C.Y. Fang, C. Cherry, K. Devarajan, T. Li, J. Malick, and M.B. Daly A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancer Gynecol Oncol 112 3 2009 594 600
29. A. Finch, K.A. Metcalfe, and J.K. Chiang The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation Gynecol Oncol 121 1 2011 163 168
30. Finch A, Metcalfe KA, Chiang JK, et al. The impact of prophylactic salpingo-oophorectomy on quality of life and psychological distress in women who carry a BRCA mutation. Psychooncology; in press.
31. D.A. Smith, J.B. Anderson, J. Shimmins, C.F. Speirs, and E. Barnett Changes in metacarpal mineral content and density in normal male and female subjects with age Clin Radiol 20 1 1969 23 31
32. J.C. Gallagher Effect of early menopause on bone mineral density and fractures Menopause 14 3 Pt 2 2007 567 571 (Pubitemid 46716174)
33. J.M. Aitken, D.M. Hart, J.B. Anderson, R. Lindsay, D.A. Smith, and C.F. Speirs Osteoporosis after oophorectomy for non-malignant disease in premenopausal women Br Med J 2 5862 1973 325 328
34. F. Pansisi, B. Bagni, and G. Bonaccorsi Oophorectomy and spine bone density: evidence of a higher rate of bone loss in surgical compared with spontaneous menopause Menopause 2 2 1995 109 115
35. L.J. Melton 3rd, S. Khosla, G.D. Malkasian, S.J. Achenbach, A.L. Oberg, and B.L. Riggs Fracture risk after bilateral oophorectomy in elderly women J Bone Miner Res 18 5 2003 900 905 (Pubitemid 37294974)
36. C. Castelo-Branco, F. Figueras, and A. Sanjuan Long-term compliance with estrogen replacement therapy in surgical postmenopausal women: benefits to bone and analysis of factors associated with discontinuation Menopause 6 4 1999 307 311 (Pubitemid 30003273)
37. C. Castelo-Branco, F. Figueras, A. Sanjuan, F. Pons, J.J. Vicente, and J.A. Vanrell Long-term postmenopausal hormone replacement therapy effects on bone mass: differences between surgical and spontaneous patients Eur J Obstet Gynecol Reprod Biol 83 2 1999 207 211 (Pubitemid 29164430)
38. W.B. Kannel, M.C. Hjortland, P.M. McNamara, and T. Gordon Menopause and risk of cardiovascular disease: the Framingham study Ann Intern Med 85 4 1976 447 452
39. K.A. Matthews, E. Meilahn, L.H. Kuller, S.F. Kelsey, A.W. Caggiula, and R.R. Wing Menopause and risk factors for coronary heart disease N Engl J Med 321 10 1989 641 646 (Pubitemid 19221308)
40. K.A. Do, A. Green, J.R. Guthrie, E.C. Dudley, H.G. Burger, and L. Dennerstein Longitudinal study of risk factors for coronary heart disease across the menopausal transition Am J Epidemiol 151 6 2000 584 593 (Pubitemid 30463603)
41. D. Kritz-Silverstein, E. Barrett-Connor, and D.L. Wingard Hysterectomy, oophorectomy, and heart disease risk factors in older women Am J Public Health 87 4 1997 676 680 (Pubitemid 27208762)
42. G.A. Colditz, W.C. Willett, M.J. Stampfer, B. Rosner, F.E. Speizer, and C.H. Hennekens Menopause and the risk of coronary heart disease in women N Engl J Med 316 18 1987 1105 1110 (Pubitemid 17052498)
43. C.M. Rivera, B.R. Grossardt, and D.J. Rhodes Increased cardiovascular mortality after early bilateral oophorectomy Menopause 16 1 2009 15 23
44. F. Atsma, M.L. Bartelink, D.E. Grobbee, and Y.T. van der Schouw Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis Menopause 13 2 2006 265 279
45. J.E. Rossouw, G.L. Anderson, and R.L. Prentice Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 288 3 2002 321 333 (Pubitemid 34761611)
46. L.T. Shuster, D.J. Rhodes, B.S. Gostout, B.R. Grossardt, and W.A. Rocca Premature menopause or early menopause: long-term health consequences Maturitas 65 2 2010 161 166
47. W.A. Rocca, B.R. Grossardt, and L.T. Shuster Oophorectomy, menopause, estrogen, and cognitive aging: the timing hypothesis Neurodegener Dis 7 1-3 2010 163 166
48. W.A. Rocca, J.H. Bower, and D.M. Maraganore Increased risk of parkinsonism in women who underwent oophorectomy before menopause Neurology 70 3 2008 200 209
49. S.M. Domchek, T.M. Friebel, and S.L. Neuhausen Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study Lancet Oncol 7 3 2006 223 229 (Pubitemid 43286452)
50. S.M. Domchek, T.M. Friebel, and C.F. Singer Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality JAMA 304 9 2010 967 975
51. A.W. Kurian, B.M. Sigal, and S.K. Plevritis Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers J Clin Oncol 28 2 2010 222 231